Hercules Capital Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered strong 2025 and Q1 2026 financial results, record new commitments, and a new supplemental dividend. All six shareholder proposals passed, including director election and plan amendments. The company highlighted its diversified portfolio and conservative balance sheet.
-
Record Q1 originations and investment income were achieved amid market volatility, with strong credit quality, robust liquidity, and a balanced portfolio across life sciences and technology. Elevated prepayments from M&A are expected in Q2, supporting continued capital redeployment.
Fiscal Year 2025
-
Record 2025 results included all-time highs in originations, fundings, and investment income, with strong credit quality and robust liquidity. The platform is well positioned for 2026, expecting continued growth, disciplined underwriting, and ongoing supplemental shareholder distributions.
-
Record Q3 results included $138.1 million in investment income and $88.6 million net investment income, with strong portfolio growth and robust liquidity. Credit quality remained high, and guidance for Q4 and 2026 remains positive, with continued confidence in dividend coverage.
-
Record Q2 results included $709.1M in gross fundings, $137.5M in investment income, and $88.7M in net investment income, with strong liquidity and improved credit quality. Outlook remains bullish for the second half of 2025, despite a seasonally slow Q3.
-
Net debt portfolio grew by nearly $270 million in Q1, with strong originations and fundings driving record performance. Liquidity exceeded $1 billion, leverage remained conservative, and credit quality was stable. Q2 guidance anticipates core yields of 12%-12.5% and higher prepayment activity.
Fiscal Year 2024
-
Record 2024 results included double-digit growth in investment income, net income, and fundings, with strong liquidity and conservative leverage. Outlook for 2025 is optimistic, with plans to increase leverage and capitalize on favorable market conditions.
-
Record Q3 and year-to-date investment income, strong liquidity, and disciplined capital deployment amid a slower venture capital environment. Conservative leverage, robust dividend coverage, and optimism for Q4 fundings despite macro and election-related uncertainties.
-
Record Q2 fundings and investment income drove strong first-half results, with robust liquidity and defensive balance sheet positioning. Asset quality remained stable, while new SBIC capital and disciplined underwriting support continued growth amid expected market volatility.